CSL.AX CSL
A$184.07 +1.62%
Asia · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+1.62%
YTD
-11.10%
P/E
—
P/B
—
ROE
—
Div yield
—
Beta
-0.31
Market cap
—
RSI (14)
64
Next earnings
—
Previous session
close of Oct 9, 2026 · EOD, no live order bookOpen
A$180.80
Close
A$184.07
VWAP (n/a)
—
Day high
A$184.13
Day low
A$180.50
Volume
351K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Haemonetics shares jump as CSL sets 2027 rollout of plasma devices
Yahoo Finance · Oct 8
CSL (ASX:CSL) Could Be 15% Undervalued After Its $355 Million Alentis Deal
Yahoo Finance · Oct 6
CSL to pay up to $1.6 bln to develop rare disease drug; shares rise
Yahoo Finance · Oct 5
Former Gilead CIO and CSL Chief Digital & Information Officer Mark Hill Joins Sware Board of Directors
Yahoo Finance · Sep 29
Why Is CSL (ASX:CSL) Launching Its New Flu Vaccine First In The UK?
Yahoo Finance · Sep 23
Expanded ANDEMBRY Reimbursement In Canada Could Be A Game Changer For CSL (ASX:CSL)
Yahoo Finance · Sep 22
Headlines via Yahoo Finance · links open the source · not an endorsement.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell CSL.AX. Try it in the Lab to size a position and see the risk.